https://priyalifescience.com/article/ireland-eu-council-presidency-pharmaceutical-policy-white-paper 2026-07-27T11:40:10+00:00 Priya Life Science en 2026-07-27T11:40:10+00:00 High Expectations, Historic Opportunity: What Ireland’s Rotating EU Council Presidency Can Deliver for European and Irish Pharma Industry, ireland eu council presidency pharmaceutical policy white paper, pharma Ireland, life science Ireland, pharmaceutical news Ireland, biopharma Europe, EMA, HPRA, biotech Ireland, MedTech Ireland https://priyalifescience.com/assets/images/irish_eu_presidency_pharma.png https://priyalifescience.com/article/resource-equation-water-power-ireland-data-centre-life-sciences-shift 2026-07-27T11:24:20+00:00 Priya Life Science en 2026-07-27T11:24:20+00:00 The Resource Equation: Decoupling Water, Power, and the Shift in Ireland’s Data Centre and Life Sciences Footprint Industry, resource equation water power ireland data centre life sciences shift, pharma Ireland, life science Ireland, pharmaceutical news Ireland, biopharma Europe, EMA, HPRA, biotech Ireland, MedTech Ireland https://priyalifescience.com/assets/images/ireland_infrastructure_shift.png https://priyalifescience.com/article/quantum-2030-ireland-national-quantum-technologies-strategy-computing 2026-07-27T11:21:52+00:00 Priya Life Science en 2026-07-27T11:21:52+00:00 Quantum 2030: How Ireland’s New Strategic Blueprint Aims to Secure Global Leadership in Quantum Computing Industry, quantum 2030 ireland national quantum technologies strategy computing, pharma Ireland, life science Ireland, pharmaceutical news Ireland, biopharma Europe, EMA, HPRA, biotech Ireland, MedTech Ireland https://priyalifescience.com/assets/images/quantum_2030_ireland.png